EAM
CMD

Eagle Asset Management’s Cantel Medical Corporation CMD Stock Holding History

Eagle Asset Management’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-351,981
Closed -$27.8M – 701
2020
Q4 		$27.8M Buy
+351,981
New +$20.6M 0.16% 192
2020
Q1 		– Sell
-258,929
Closed -$18.4M – 681
2019
Q4 		$18.4M Buy
258,929
+968
+0.4% +$70.2K 0.09% 239
2019
Q3 		$19.3M Sell
257,961
-49,355
-16% -$4.18M 0.1% 230
2019
Q2 		$24.8M Buy
307,316
+90,440
+42% +$6.36M 0.13% 221
2019
Q1 		$14.5M Buy
216,876
+52,315
+32% +$3.96M 0.08% 253
2018
Q4 		$12.3M Buy
164,561
+35,026
+27% +$2.89M 0.08% 261
2018
Q3 		$11.9M Buy
129,535
+19,287
+17% +$1.84M 0.06% 321
2018
Q2 		$10.8M Sell
110,248
-5,359
-5% -$599K 0.06% 316
2018
Q1 		$12.9M Buy
115,607
+8,768
+8% +$983K 0.07% 291
2017
Q4 		$11M Sell
106,839
-22,359
-17% -$2.23M 0.06% 313
2017
Q3 		$12.8M Sell
129,198
-12,770
-9% -$1.01M 0.07% 309
2017
Q2 		$11.1M Buy
141,968
+38,078
+37% +$2.86M 0.07% 315
2017
Q1 		$8.32M Buy
103,890
+1,617
+2% +$129K 0.05% 343
2016
Q4 		$8.05M Buy
102,273
+1,438
+1% +$112K 0.05% 342
2016
Q3 		$7.86M Buy
100,835
+57
+0.1% +$4.13K 0.05% 352
2016
Q2 		$6.93M Sell
100,778
-40,344
-29% -$2.78M 0.05% 368
2016
Q1 		$10.1M Sell
141,122
-11,241
-7% -$706K 0.07% 320
2015
Q4 		$9.47M Sell
152,363
-20,598
-12% -$1.26M 0.06% 339
2015
Q3 		$9.81M Sell
172,961
-9,866
-5% -$522K 0.07% 333
2015
Q2 		$9.81M Sell
182,827
-205,485
-53% -$10M 0.06% 332
2015
Q1 		$18.4M Sell
388,312
-74,788
-16% -$3.31M 0.11% 237
2014
Q4 		$20M Sell
463,100
-23,214
-5% -$948K 0.12% 223
2014
Q3 		$16.7M Sell
486,314
-26,835
-5% -$948K 0.1% 232
2014
Q2 		$18.8M Sell
513,149
-229,424
-31% -$7.78M 0.1% 234
2014
Q1 		$25M Buy
742,573
+11,134
+2% +$367K 0.14% 210
2013
Q4 		$24.8M Sell
731,439
-102,860
-12% -$3.56M 0.14% 206
2013
Q3 		$25.5M Sell
834,299
-125,788
-13% -$3.35M 0.13% 210
2013
Q2 		$21.7M Buy
+960,087
New +$20.8M 0.14% 206

Other funds holding CMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
LGP
Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Eagle Asset Management's CMD Position: Q1 2021 in Review

Eagle Asset Management sold out of Cantel Medical Corporation (CMD) in Q1 2021, closing a stake of 351,981 shares — an estimated $27.8M sold.

Eagle Asset Management first reported a position in CMD in Q2 2013 and held it in 28 quarters. The position peaked at $27.8M in Q4 2020. 234 funds tracked by Wall St. Rank hold CMD as of Q1 2021.

  • Eagle Asset Management reported no remaining Cantel Medical Corporation position as of Q1 2021 after selling out during the quarter.
  • Eagle Asset Management sold 351,981 Cantel Medical Corporation shares in Q1 2021, an estimated $27.8M.
  • Eagle Asset Management first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 28 quarters.
  • Eagle Asset Management's Cantel Medical Corporation position peaked at $27.8M in Q4 2020.
  • 234 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2021.

Based on Eagle Asset Management's 13F filing for Q1 2021, filed 14 May 2021.